These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10102941)

  • 1. Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications.
    Jones AL; Simpson KJ
    Aliment Pharmacol Ther; 1999 Feb; 13(2):129-33. PubMed ID: 10102941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute liver failure following the use of ecstasy (MDMA)].
    Lange-Brock N; Berg T; Müller AR; Fliege H; Neuhaus P; Wiedenmann B; Klapp BF; Mönnikes H
    Z Gastroenterol; 2002 Aug; 40(8):581-6. PubMed ID: 12297982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Death after the intake of amphetamine/ecstasy: two case reports].
    Wöllner K; Stockhausen S; Mußhoff F; Madea B
    Arch Kriminol; 2015; 235(1-2):53-61. PubMed ID: 26419092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amphetamine, ecstasy and cocaine. Clinical aspects of acute poisoning].
    Hedetoft C; Christensen HR
    Ugeskr Laeger; 1999 Dec; 161(50):6907-11. PubMed ID: 10643376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Accidental amphetamine poisoning in an 11-month-old boy].
    Fogel S; Lesage F; Cheron G
    Arch Pediatr; 2016 Aug; 23(8):820-2. PubMed ID: 27345557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and toxicological evaluation of fatal poisoning with amphetamine derivative--MDMA, ecstasy (3,4-methylenedioxymethamphetamine)].
    Lukasik-Głebocka M; Wachowiak R; Kostrzewa A; Karlikowski M; Mańkowski W; Kołowski J
    Przegl Lek; 2004; 61(4):410-3. PubMed ID: 15521617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecstasy induced acute hepatic failure. Case reports.
    Atayan Y; Çağın YF; Erdoğan MA; Harputluoglu MM; Bilgic Y
    Acta Gastroenterol Belg; 2015; 78(1):53-5. PubMed ID: 26118578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option.
    Garbino J; Henry JA; Mentha G; Romand JA
    Vet Hum Toxicol; 2001 Apr; 43(2):99-102. PubMed ID: 11308131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying the hepatotoxic effects of ecstasy.
    Carvalho M; Pontes H; Remião F; Bastos ML; Carvalho F
    Curr Pharm Biotechnol; 2010 Aug; 11(5):476-95. PubMed ID: 20420570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Variability of the clinical expression of Ecstasy-induced hepatotoxicity].
    Núñez O; Bañares R; Barrio J; Menchén L; Diego Ad; Salinero E; Clemente G
    Gastroenterol Hepatol; 2002 Oct; 25(8):497-500. PubMed ID: 12361531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ecstasy (MDMA) intoxication. An overview].
    Dinse H
    Anaesthesist; 1997 Aug; 46(8):697-703. PubMed ID: 9382208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperkalemia in fatal MDMA ('ecstasy') toxicity.
    Raviña P; Quiroga JM; Raviña T
    Int J Cardiol; 2004 Feb; 93(2-3):307-8. PubMed ID: 14975567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "ADAM' or "EVE'?--a toxicological conundrum.
    Cox DE; Williams KR
    Forensic Sci Int; 1996 Jan; 77(1-2):101-8. PubMed ID: 8675130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.
    Kalant H
    CMAJ; 2001 Oct; 165(7):917-28. PubMed ID: 11599334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Ecstasy" associated deaths: what is a fatal concentration ? Analysis of a case series.
    Milroy CM
    Forensic Sci Med Pathol; 2011 Sep; 7(3):248-52. PubMed ID: 21264549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyolysis in MDMA intoxication: a rapid and underestimated killer. "Clean" Ecstasy, a safe party drug?
    Vanden Eede H; Montenij LJ; Touw DJ; Norris EM
    J Emerg Med; 2012 Jun; 42(6):655-8. PubMed ID: 19500935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecstasy-induced brain death and acute hepatocellular failure: multiorgan donor and liver transplantation.
    Caballero F; Lopez-Navidad A; Cotorruelo J; Txoperena G
    Transplantation; 2002 Aug; 74(4):532-7. PubMed ID: 12352914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasy.
    Brauer RB; Heidecke CD; Nathrath W; Beckurts KT; Vorwald P; Zilker TR; Schweigart U; Hölscher AH; Siewert JR
    Transpl Int; 1997; 10(3):229-33. PubMed ID: 9163865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does hyperthyroidism increase risk of death due to the ingestion of ecstasy?
    Martin TL; Chiasson DA; Kish SJ
    J Forensic Sci; 2007 Jul; 52(4):951-3. PubMed ID: 17524054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatality due to combined use of the designer drugs MDMA and PMA: a distribution study.
    Dams R; De Letter EA; Mortier KA; Cordonnier JA; Lambert WE; Piette MH; Van Calenbergh S; De Leenheer AP
    J Anal Toxicol; 2003; 27(5):318-22. PubMed ID: 12908947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.